Brief: 4D Molecular Therapeutics Reports FY 2022 Financial Results And Operational Highlights
15/03/2023 20:15
March 15 (Reuters) - 4D Molecular Therapeutics Inc
FDMT.O :
* 4D MOLECULAR THERAPEUTICS REPORTS FULL YEAR 2022 FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* 4D MOLECULAR THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES SUFFICIENT TO FUND OPERATIONS INTO FIRST
HALF OF 2025
Source text for Eikon: ID:nGNX3L2pB7
Further company coverage: FDMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings